Gabriela Saborio

Title: Gabriela Saborio: Innovator in Therapeutic Polypeptides

Introduction

Gabriela Saborio is a prominent inventor based in Dingy en Vuache, France. She has made significant contributions to the field of therapeutic polypeptides, particularly in the context of treating inflammatory and autoimmune disorders. Her innovative work has led to the development of valuable patents that aim to improve health outcomes.

Latest Patents

Gabriela holds 1 patent for her invention titled "Soluble CD164 polypeptides." This patent focuses on sCD164 variants and their therapeutic uses, specifically targeting the treatment and prevention of inflammatory or autoimmune disorders. Her research in this area showcases her commitment to advancing medical science and improving patient care.

Career Highlights

Gabriela is currently employed at Merck Serono S.A., a leading biopharmaceutical company. Her role at Merck Serono allows her to collaborate with other experts in the field and contribute to groundbreaking research. Her dedication to innovation and excellence has positioned her as a key player in her area of expertise.

Collaborations

Gabriela has worked alongside talented colleagues, including Christine Power and Amanda Proudfoot. These collaborations have fostered a dynamic environment for research and development, enhancing the impact of their collective work.

Conclusion

Gabriela Saborio's contributions to the field of therapeutic polypeptides exemplify her innovative spirit and dedication to improving health outcomes. Her work continues to inspire advancements in medical research and treatment options.